Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
263.94
-1.59 (-0.60%)
May 30, 2025, 9:30 AM - Market open
Penumbra Employees
Penumbra had 4,500 employees as of December 31, 2024. The number of employees increased by 300 or 7.14% compared to the previous year.
Employees
4,500
Change (1Y)
300
Growth (1Y)
7.14%
Revenue / Employee
$275,578
Profits / Employee
$9,385
Market Cap
10.22B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4,500 | 300 | 7.14% |
Dec 31, 2023 | 4,200 | 300 | 7.69% |
Dec 31, 2022 | 3,900 | 100 | 2.63% |
Dec 31, 2021 | 3,800 | 500 | 15.15% |
Dec 31, 2020 | 3,300 | 600 | 22.22% |
Dec 31, 2019 | 2,700 | 500 | 22.73% |
Dec 31, 2018 | 2,200 | 500 | 29.41% |
Dec 31, 2017 | 1,700 | 200 | 13.33% |
Dec 31, 2016 | 1,500 | 400 | 36.36% |
Dec 31, 2015 | 1,100 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
PEN News
- 9 days ago - Penumbra, Inc. to Present at Upcoming Investor Conferences - PRNewsWire
- 4 weeks ago - Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference - PRNewsWire
- 4 weeks ago - Baron Health Care Fund Q1 2025 Top Net Purchases And Sales - Seeking Alpha
- 5 weeks ago - Penumbra Among Well-Insulated Companies From Ongoing Tariff Dynamics, Says Analyst - Benzinga
- 5 weeks ago - Penumbra, Inc. (PEN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Penumbra, Inc. Reports First Quarter 2025 Financial Results - PRNewsWire
- 2 months ago - Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025 - PRNewsWire
- 2 months ago - Seven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits - PRNewsWire